523 related articles for article (PubMed ID: 34289966)
21. Combination of procalcitonin and C-reactive protein levels in the early diagnosis of bacterial co-infections in children with H1N1 influenza.
Li Z; He L; Li S; He W; Zha C; Ou W; Hou Q; Wang W; Sun X; Liang H
Influenza Other Respir Viruses; 2019 Mar; 13(2):184-190. PubMed ID: 30443990
[TBL] [Abstract][Full Text] [Related]
22. Clinical Characteristics Associated with Return Visits to the Emergency Department after COVID-19 Diagnosis.
Husain I; O'Neill J; Mudge R; Bishop A; Soltany KA; Heinen J; Countryman C; Casey D; Cline D
West J Emerg Med; 2021 Nov; 22(6):1257-1261. PubMed ID: 34787548
[TBL] [Abstract][Full Text] [Related]
23. Identifying patients with bacterial infections using a combination of C-reactive protein, procalcitonin, TRAIL, and IP-10 in the emergency department: a prospective observational cohort study.
van der Does Y; Rood PPM; Ramakers C; Schuit SCE; Patka P; van Gorp ECM; Limper M
Clin Microbiol Infect; 2018 Dec; 24(12):1297-1304. PubMed ID: 30268671
[TBL] [Abstract][Full Text] [Related]
24. Co-Infection with Common Respiratory Pathogens and SARS-CoV-2 in Patients with COVID-19 Pneumonia and Laboratory Biochemistry Findings: A Retrospective Cross-Sectional Study of 78 Patients from a Single Center in China.
Tang ML; Li YQ; Chen X; Lin H; Jiang ZC; Gu DL; Chen X; Tang CX; Xie ZQ
Med Sci Monit; 2021 Jan; 27():e929783. PubMed ID: 33388738
[TBL] [Abstract][Full Text] [Related]
25. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
[TBL] [Abstract][Full Text] [Related]
26. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients.
Carbonell R; Urgelés S; Salgado M; Rodríguez A; Reyes LF; Fuentes YV; Serrano CC; Caceres EL; Bodí M; Martín-Loeches I; Solé-Violán J; Díaz E; Gómez J; Trefler S; Vallverdú M; Murcia J; Albaya A; Loza A; Socias L; Ballesteros JC; Papiol E; Viña L; Sancho S; Nieto M; Del M; Lorente C; Badallo O; Fraile V; Arméstar F; Estella A; Abanses P; Sancho I; Guasch N; Moreno G;
J Infect; 2022 Oct; 85(4):374-381. PubMed ID: 35781017
[TBL] [Abstract][Full Text] [Related]
27. The value of clinical parameters in predicting the severity of COVID-19.
Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
[TBL] [Abstract][Full Text] [Related]
28. A biomarker based severity progression indicator for COVID-19: the Kuwait prognosis indicator score.
Jamal MH; Doi SA; AlYouha S; Almazeedi S; Al-Haddad M; Al-Muhaini A; Al-Ghimlas F; Chowdhury ME; Al-Sabah S
Biomarkers; 2020 Dec; 25(8):641-648. PubMed ID: 33090050
[TBL] [Abstract][Full Text] [Related]
29. LDH, CRP and ALB predict nucleic acid turn negative within 14 days in symptomatic patients with COVID-19.
Liu G; Zhang B; Zhang S; Hu H; Liu T
Scott Med J; 2021 Aug; 66(3):108-114. PubMed ID: 33663273
[TBL] [Abstract][Full Text] [Related]
30. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
[TBL] [Abstract][Full Text] [Related]
31. Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.
Myhre PL; Prebensen C; Strand H; Røysland R; Jonassen CM; Rangberg A; Sørensen V; Søvik S; Røsjø H; Svensson M; Berdal JE; Omland T
Circulation; 2020 Dec; 142(22):2128-2137. PubMed ID: 33058695
[TBL] [Abstract][Full Text] [Related]
32. Low prevalence of SARS-CoV-2 in plasma of COVID-19 patients presenting to the emergency department.
Nijhuis RHT; Russcher A; de Jong GJ; Jong E; Herder GJM; Remijn JA; Verweij SP
J Clin Virol; 2020 Dec; 133():104655. PubMed ID: 33069846
[TBL] [Abstract][Full Text] [Related]
33. Outcome prediction using the Mortality in Emergency Department Sepsis score combined with procalcitonin for influenza patients.
Teng F; Wan TT; Guo SB; Liu X; Cai JF; Qi X; Liu WX
Med Clin (Barc); 2019 Dec; 153(11):411-417. PubMed ID: 31174861
[TBL] [Abstract][Full Text] [Related]
34. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.
Courtais C; Kuster N; Dupuy AM; Folschveiller M; Jreige R; Bargnoux AS; Guiot J; Lefebvre S; Cristol JP; Sebbane M
Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327
[TBL] [Abstract][Full Text] [Related]
35. Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts.
Castro VM; McCoy TH; Perlis RH
JAMA Netw Open; 2020 Oct; 3(10):e2023934. PubMed ID: 33125498
[TBL] [Abstract][Full Text] [Related]
36. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
Zhao Y; Yin L; Patel J; Tang L; Huang Y
J Med Virol; 2021 Jul; 93(7):4358-4369. PubMed ID: 33739452
[TBL] [Abstract][Full Text] [Related]
37. A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center.
Rodriguez-Nava G; Yanez-Bello MA; Trelles-Garcia DP; Chung CW; Egoryan G; Friedman HJ
Med Sci Monit; 2020 Nov; 26():e928754. PubMed ID: 33188161
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory markers are poorly predictive of clinical outcomes among hospitalized patients with COVID-19.
Barrett B; Pamphile S; Yang F; Naeem F; Kim J; Annam J; Borczuk R; Yellin S; Bass C; Fowler S; Mosheyev M; Mayer YJ; Friedman BW
Am J Emerg Med; 2021 Aug; 46():595-598. PubMed ID: 33280969
[TBL] [Abstract][Full Text] [Related]
39. Procalcitonin and C-reactive protein perform better than the neutrophil/lymphocyte count ratio in evaluating hospital acquired pneumonia.
Zheng N; Zhu D; Han Y
BMC Pulm Med; 2020 Jun; 20(1):166. PubMed ID: 32527243
[TBL] [Abstract][Full Text] [Related]
40. Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients.
Kooistra EJ; van Berkel M; van Kempen NF; van Latum CRM; Bruse N; Frenzel T; van den Berg MJW; Schouten JA; Kox M; Pickkers P
Crit Care; 2021 Aug; 25(1):281. PubMed ID: 34353339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
